Preparation and Properties of 5-Fluorouracil-Loaded Chitosan Microspheres for the Intranasal Administration

Abstract

Objective To study the preparation technique of 5-fluorouracil and the release characteristic of 5-fluorouracil-loaded chitosan microspheres for the intranasal administration.

Methods 5-fluorouracil-loaded chitosan microspheres were prepared by emulsion chemical cross-link technique. The orthogonal experimental design was used to optimize the preparation procedure. Dynamic dialysis method was applied to determine the release characteristic of microspheres in vitro and its influencing factors. Swelling behavior was expressed by swelling ratio. The degree of mucoadhesion was investigated by determining the mucociliary transport rate(MTR) of the microparticle across a frog palate.

Results Microspheres with a good shape and narrow size distribution were prepared. The average diameter was 43±4 μm. The drug loading was (38.5±1.0) %. The entrapment efficiency was (79.0±1.8) %. The drug release profile in vitro could be described by Higuichi eqution as Q=0.1035t^1/2+0.0284 (r=0.9965). Chitosan had good mucoadhesive property and caused a significant reduction in MTR(P<0.01).

Conclusion The optimized technique has a good reproducibility and a high entrapment efficiency, so it could be used to prepare 5-fluorouracil-loaded chitosan microspheres for the intranasal administration.Chitosan is a good material for nasal preparation and has prospective development in the pharmaceutical field.

Key words

flourouracil: chitosan - microspheres - drug carriers

^* Wanqing Li mainly contributed to the study

• References

• 1 Papademetriou IT, Porter T. Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer. Therapeutic Delivery 2015; 6: 989
• 2 Abbott NJ. Blood-brain barrier structure and function and the challenges for CNS drug delivery. Journal of Inherited Metabolic Disease 2013; 36: 437
• 3 Pardridge WM. Non-invasive drug delivery to the human brain using endogenous blood-brain barrier transport systems. Pharmaceutical Science & Technology Today 1999; 2: 49
• 4 Illum L. Transport of drugs from the nasal cavity to the central nervous system. European Journal of Pharmaceutical Sciences Official Journal of the European Federation for Pharmaceutical Sciences 2000; 11: 1-18
• 5 Tayebati SK, Nwankwo IE, Amenta F. Intranasal drug delivery to the central nervous system: present status and future outlook. Current Pharmaceutical Design 2013; 19: 510-526
• 6 Hersh DS, Wadajkar AS, Roberts NB. et al. Evolving drug delivery strategies to overcome the blood brain barrier. Current Pharmaceutical Design 2016; 22: 1177-1193
• 7 Sakane T, Yamashita S, Yata N. et al. Transnasal delivery of 5-fluorouracil to the brain in the rat. Journal of Drug Targeting 1999; 7: 233-240
• 8 Denkbaş EB, Seyyal M, Pişkin E. Implantable 5-fluorouracil loaded chitosan scaffolds prepared by wet spinning. Journal of Membrane Science 2000; 172: 33-38
• 9 Ahmed TA, Aljaeid BM. Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery. Drug Design Development & Therapy 2016; 10: 483
• 10 Lim ST, Martin GP, Berry DJ. et al. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. Journal of Controlled Release 2000; 66: 281-292
• 11 Clementino A, Batger M, Garrastazu G. et al. The nasal delivery of nanoencapsulated statins – an approach for brain delivery. International Journal of Nanomedicine 2016; 11: 6575-6590
• 12 Wang K, Kievit FM, Florczyk SJ. et al. 3D Porous Chitosan–Alginate Scaffolds as an In Vitro Model for Evaluating Nanoparticle-Mediated Tumor Targeting and Gene Delivery to Prostate Cancer. Biomacromolecules 2015; 16: 3362-3372
• 13 Hassan EE, Parish RC, Gallo JM. Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole. Pharmaceutical Research 1992; 9: 390-397
• 14 Sheu MT, Sokoloski TD. Entrapment of bioactive compounds within native albumin beads: III. Evaluation of parameters affecting drug release. Journal of Parenteral Science & Technology A Publication of the Parenteral Drug Association 1986; 40: 259
• 15 Chaturvedi K, Kulkarni AR, Aminabhavi TM. Blend microspheres of poly(3-hydroxybutyrate) and cellulose acetate phthalate for colon delivery of 5-fluorouracil. Industrial & Engineering Chemistry Research 2011; 50: 10414-10423
• 16 Gudasi KB, Vadavi RS, Shelke NB. et al. Synthesis and characterization of novel polyorganophosphazenes substituted with 4-methoxybenzylamine and 4-methoxyphenethylamine for in vitro release of indomethacin and 5-fluorouracil. Reactive & Functional Polymers 2006; 66: 1149-1157
• 17 Babu VR, Sairam M, Hosamani KM. et al. Development of 5-fluorouracil loaded poly(acrylamide- co -methylmethacrylate) novel core-shell microspheres: In vitro release studies . International Journal of Pharmaceutics 2006; 325: 55
• 18 Thakker SP, Rokhade AP, Abbigerimath SS. et al. Inter-polymer complex microspheres of chitosan and cellulose acetate phthalate for oral delivery of 5-fluorouracil. Polymer Bulletin 2014; 71: 2113-2131
• 19 Reddy KM, Babu VR, Rao KSVK. et al. Temperature sensitive semi-IPN microspheres from sodium alginate and N-isopropylacrylamide for controlled release of 5-fluorouracil. Journal of Applied Polymer Science 2010; 107: 2820-2829
• 20 Woensel MV, Wauthoz N, Rosière R. et al. Formulations for intranasal delivery of pharmacological agents to combat brain disease: A new opportunity to tackle GBM?. Cancers 2013; 5: 1020